SanaClis Connecting with Global Regulatory Authorities

Bratislava, Slovakia – 8 September 2026 

SanaClis was honoured to welcome a delegation from the Shanghai FDA, China, to SanaClis as part of their official visit to Slovakia

The delegation was led by Mr. Yuxiang Zhao, Director of the Shanghai Medical Products Administration (Shanghai FDA), and consisted of six members, including several Heads of Departments.

During their official Slovak visit, the delegation also met with senior representatives of ŠÚKL, the Slovak regulatory authority. We are particularly proud that ŠÚKL selected SanaClis as one of the organisations for the Shanghai delegation to visit during their programme.

At SanaClis, CEO Alexander Fetkovsky, COO Roman Hrynchuk and VP Clinical Supply Chain / QP Marian Kulich welcomed the delegation and provided an overview of our comprehensive services. The discussion focused on regulatory processes as well as the roles, responsibilities and competencies of CROs and CMOs.

We are proud to be actively involved in discussions with regulatory authorities from different parts of the world and to contribute to the exchange of knowledge and perspectives across the clinical research and pharmaceutical landscape.

Our sincere thanks to ŠÚKL for selecting SanaClis for this visit and to Mr. Yuxiang Zhao and the Shanghai FDA delegation for the engaging discussion and interest in our work.